Biora Therapeutics (BIOR) Misses Q3 EPS by 504c

Biora Therapeutics (NASDAQ: BIOR) reported Q3 EPS of ($5.04). Revenue for the quarter came in at $30 thousand.

For earnings history and earnings-related data on Biora Therapeutics (BIOR) click here.

You May Also Be Interested In

• Qualcomm plans new chip architecture for phones - Semafor
• Apple’s Vision Pro And Smart Glasses Chief To Leave For OpenAI - Bloomberg
• SEGG Media sues short seller for $20M over stock report